Advertisement
Home Tags Immune Disorders

Tag: Immune Disorders

For patients with granulomatosis with polyangiitis or microscopic polyangiitis

Long-Term Rituximab May Aid in Antibody-Associated Vasculitis

0
Relapse rates lower versus placebo in granulomatosis with polyangiitis, microscopic polyangiitis
The prevalence of antinuclear antibodies in the United States has increased considerably between 1988 and 2012

Prevalence of Autoimmunity May Be on the Rise

0
Reasons for increasing prevalence among broad subgroups from 1988 to 2012 remain unclear
The spectrum of pediatric syndromes associated with myelin oligodendrocyte glycoprotein antibodies is wider than previously thought

Broad Clinical Spectrum Linked to Pediatric MOG Antibodies

0
Presenting syndromes include ADEM, encephalitis other than ADEM, optic neuritis, myelitis

American College of Rheumatology, Nov. 8-13

0
The 83rd Annual Meeting of the American College of Rheumatology The annual meeting of the American College of Rheumatology was held from...
In thrombotic antiphospholipid antibody syndrome

Study Compares Anticoagulants for Antiphospholipid Syndrome

0
Authors find rivaroxaban not noninferior to vitamin K antagonists for secondary thromboprophylaxis
From 1999 to 2017

Mortality Down for Autoantibody-Associated Vasculitides Patients

0
Average annual decline of 1.6 percent in AAV-related mortality rate seen from 1999 to 2017 in the U.S.
Patients with autoimmune diseases have an increased risk for being diagnosed with Crohn disease or ulcerative colitis while under treatment with etanercept

Etanercept Tx for Autoimmune Disease May Up Risk for IBD

0
Findings seen in patients receiving etanercept for other autoimmune diseases
Common autoimmune disorders are associated with an increased risk for carpal tunnel syndrome

Autoimmune Disorders May Up Risk for Carpal Tunnel Syndrome

0
Hazard ratio for developing CTS significantly increased for Sjögren syndrome, rheumatoid arthritis
Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome.

FDA Approves Firdapse for Rare Autoimmune Disorder

0
First agency-sanctioned treatment for adults with Lambert-Eaton myasthenic syndrome
The U.S. Food and Drug Administration on Monday approved Gamifant (emapalumab-lzsg) for the treatment of primary hemophagocytic lymphohistiocytosis (HLH) in pediatric (as young as newborn) and adult patients who have refractory

FDA Approves Drug to Treat Rare Immune Disease

0
Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis